Sanofi Stock Forecast 2026–2030 | Future Outlook
Sanofi (SAN) is trading around €83.41 as of 11:54am on 9 January 2026 (UTC), within an intraday range of €82.55–€83.60 on Capital.com’s euro-denominated stock CFD for the French listing. Past performance is not a reliable indicator of future results.
The stock is trading amid a series of company-specific developments. These include Sanofi’s announcement that the US Food and Drug Administration has accepted a priority review application to extend the use of its type 1 diabetes drug Tzield to younger children, with a decision expected in late April 2026 (Sanofi, 5 January 2026). Recent trading has also taken place against the backdrop of additional strategic updates, including an AI-enabled autoimmune drug discovery…
